Posts written by hai-admin

Selected R&D demonstration projects disappointing: Innovation models with new incentive mechanisms needed

by TESSEL MELLEMA The World Health Organization Executive Board adopted a draft decision to begin the implementation of eight rather meager research and development (R&D) demonstration projects last week, despite…

30 January 2014

Regulation critical to clinical trials data transparency in Europe

By ANCEL.LA SANTOS QUINTANO Access to full clinical trials data is crucial to evidence-based medicine and the protection of public health. Unfortunately, limited access to clinical data held by drug…

23 January 2014

When politicians go to the movies

By LEAH COWAN As part of the Global Health Summer School, which we co-organised in Berlin this September, HAI arranged a preview screening of the documentary, Fire in the Blood. The film…

25 November 2013

True clinical trials transparency? Not quite, EFPIA.

By ANCEL.LA SANTOS QUINTANOLast week, the European Federation of Pharmaceutical Industries and Associations (EFPIA) posted a videoon You Tube, called Clinical Trials and Transparency. In it, EFPIA claims to be…

Conference contemplations: ‘Pharmaceuticals and global health – inequalities and innovation in the 21st century’

By LEAH COWAN On 19 July, over 150 participants from consumer groups, policy and research bodies, universities and NGOs attended the annual Global Health Conference at the University of Sussex:…

Good week for access to affordable medicines

By TESSEL MELLEMA Just days after the United States (US) Supreme Court granted American regulators the legal right to investigate and fine pay-for-delay deals between originator and generics pharmaceutical companies,…

Despite concrete steps forward, the ENVI vote on clinical trials regulation falls short on transparency

By ANCEL.LA SANTOS QUINTANOOn 29 May 2013 the European Parliament’s Environment, Public Health and Food Safety (ENVI) Committee voted unanimously in favour of a draft body of rules governing the…

Bracing for another delay – open innovation at the WHO?

By SOPHIE BLOEMEN, Advisor to Health Action InternationalOpen innovation, open access, crowd-sourcing innovation, innovation prizes… All are buzzwords we often hear in the media, employed by entrepreneurs, government officials or…

EU Policy Opportunities in Biomedical Innovation and the Public Good

Together with the Trans Atlantic Consumer Dialogue (TACD), HAI Europe is currently finalising a policy paper on biomedical innovation for the European level. Sophie Bloemen and David Hammerstein are now…

2 December 2011

Statement on Medicines Patent Pool

HAI Global and HAI Europe congratulate the Medicines Patent Pool (MPP) on the licensing agreement with generic companies, most notably Aurobindo. The sublicenses are a major step forward in the…

13 October 2011

Public Event on EU-MERCOSUR in Buenos Aires

On Friday the 29th of July the first public event on the MERCOSUR-EU negotiations took place in the University of Buenos Aires, Argentina. Organized by the research institute CEIDIE, speakers…

Study provides recommendations on European Medicines Agency's communication on medicines

A recently published study produced by an independent expert offers recommendations to assist the European Medicines Agency’s communication on the benefits and risks of medicines. The report is a result…

The Diagnosis of Childhood Bipolar Disease has led to Catastrophic Consequences

There has been a call for the diagnosis of childhood bipolar disease to be axed from the Diagnostic and Statistical Manual of Mental Disorders (DSM) by one of its early…

DG Trade State of Play reveals EU's ambitions for IP protection in FTAs

The EU will not be changing its aggressive approach to IP protection in bilateral trade agreements, according to the updates that representatives from the European Commission gave at a State…

TRIPS-Plus IP demands from EU could halt South American trade deal

13 June 2011 Negotiations for a trade agreement between the EU and South American trade bloc Mercosur are approaching yet another impasse, just a year after re-launching the talks. Free…

EU Mercosur Trade Negotiations in July

All eyes have been on the European Union (EU)-India trade agreement, and the repercussions it will have on access to medicines, not only in India but also in the many…

HAI Europe’s participation at the “Ad hoc meeting – Bilateral trade negotiations: State of Play”

HAI Europe will attend the DG Trade Civil Society “Ad hoc meeting – Bilateral trade negotiations: State of Play” in Brussels on the 27th of June. The purpose of the…

Conflicts of interest at the European Medicines Agency (EMA) and the need for a review of staff regulations

20 June 2011 Joint Open Letter to Commissioner Dalli on conflicts of interest at the European Medicines Agency (EMA) and the need for a review of staff regulations On 20…

Submission to the Consultative Expert Working Group (CEWG) on alternative financing

In June 2011 (HAI) Global, HAI Latin America and the Caribbean (AISLAC) and HAI Europe (HAI-E) made a submission to the Consultative Expert Working Group (CEWG) on alternative financing. For…

HAI Europe injects public health perspective into European Research and Innovation Framework

24 May 2011 Last Friday, 20 May 2011, Health Action International (HAI) Europe submitted a response to the European Commission consultation on the Common Strategic Framework (CSF) for Research and…

Statement on conflicts of interest delivered at WHA on behalf of HAI, Berne Declaration, KEI, TWN, PHM, IBFAN

Today Health Action International, represented by one of its members, Patrick Durisch, delivered the following statement at the World Health Assembly in Geneva on Agenda Item 13.5 Global Immunization Vision…

Conflicts of Interest and the Future of Financing for WHO.

Statement on WHO governance and the Management of Conflicts of Interest and the Future of Financing for WHO. We write to express our concerns about governance of the World Health…

DG Trade public hearing on the “Protection and enforcement of IPR in third countries

Today, DG Trade held a public hearing on the “Protection and enforcement of IPR in third countries” from 9.00-13.30, at the Albert Borschette Conference Centre in Brussels Health Action International…

EU-Mercosur Trade Negotiations: What Fate for Access to medicines?

Trade negotiators from the EU and Mercosur countries (Argentina, Brazil, Paraguay, Uruguay and Venezuela) will meet next week from 2 to 6 May in Asuncion, Paraguay for the latest round…

Foundations: Conlicts of interests and Democracy issues

http://www.plosmedicine.org/article/info%3Adoi%2F10.1371%2Fjournal.pmed.1001020 The article ‘Global Health Philanthropy and Institutional Relationships: How Should Conflicts of Interest Be Addressed? ‘ published in Plos Medicine on the 14th of April on conflicts of interest…

European drug regulator challenged over revolving door case involving former Director

Public health and transparency advocates ask the European Commission if rules regarding conflicts of interest have been sufficiently and duly respected in light of the EMA’s decision to allow its…

25 February 2011

Corporate funding linked to EU patient & consumer groups policy

HAI Europe’s latest research has established a link between patient and consumer groups’ perspectives on EU medicines policies and the funding they receive from the pharmaceutical industry. Please see our…

1 February 2011

Apply now: HAI Europe recruits two interns for 2011

HAI Europe is recruiting two volunteer interns to begin in early 2011. The successful applicants will gain valuable experience of working in an international advocacy NGO and exposure to the…

22 December 2010

EMA reviews transparency criteria

The European Medicines Agency (EMA) has launched an internal review of the transparency criteria that patient and consumer organisations need to fulfill in order to be eligible to work with…

20 December 2010

HAI research on financial disclosure featured in article: European politicians' call for greater transparency

The physicians’ magazine Deutsches Aerzteblatt highlights HAI Europe’s research on financial dislcosure & transparency of patient and consumer groups in an article examining European politicians’ call for greater transparency of…

1 December 2010